TherapeuticsMD, Inc. (TXMD) Stock Overview
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe…
Source: Yahoo Finance
Sector & Industry
TherapeuticsMD, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the NASDAQ exchange.
TherapeuticsMD, Inc. at a Glance
| Company | TherapeuticsMD, Inc. |
| Ticker | TXMD |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $2.21 |
| Market cap | $25.58M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$0.03 |
| 52-week high | $2.95 |
| 52-week low | $0.99 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.65 |
| Return on equity (ROE) | -1.08% |
| Debt-to-equity | 20.49% |
| Average volume | 38,387 |
| Shares outstanding | 11.57M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 1 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is TherapeuticsMD, Inc.'s current P/E ratio?
- TherapeuticsMD, Inc. (TXMD) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is TherapeuticsMD, Inc.'s market capitalisation?
- TherapeuticsMD, Inc.'s market cap is $25.58M based on our latest snapshot. See how it ranks by market cap →
- What is TXMD's 52-week range?
- Over the past 52 weeks, TXMD has traded between $0.99 and $2.95. What does the 52-week range mean? →
- How volatile is TherapeuticsMD, Inc. compared to the market?
- TherapeuticsMD, Inc. has a beta of 0.65, meaning it has historically moved less than the broader market. What does beta measure? →
- Does TherapeuticsMD, Inc. pay a dividend?
- TherapeuticsMD, Inc. does not currently pay a dividend according to our latest data.
- What exchange is TXMD listed on?
- TXMD is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is TherapeuticsMD, Inc. in?
- TherapeuticsMD, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →